New PhDs to train the next generation of bio-scientists

MedImmune, the global biologics research and development arm of AstraZeneca, and a consortium of Leeds, Cambridge, Manchester and Sheffield universities has secured a Collaborative Training Partnership, structured as 12 PhD studentships.

The studentships are designed to invest in the training of the next generation of scientists for the wider bioeconomy and research base, providing access to facilities and expertise unavailable in an academic setting alone.

Working collaboratively, MedImmune and the universities will co-locate the four-year-long studentships to advance discovery and development in Industrial Biotechnology and Bioenergy. Read more.